Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01212159 · ClinicalTrials.gov registry record · Phase 4
Telephone Based Management of Hyperlipidemia
A Phase 4 study of Hyperlipidemia, sponsored by Temple University.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT01212159: Completed Phase 4 study of Hyperlipidemia, sponsored by Temple University.
NCT01212159 is a Phase 4 study of Hyperlipidemia that has completed, run by Temple University. The registered enrollment target is 70 participants, below the 406-participant average among 35 other Hyperlipidemia trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01212159, a Phase 4 study of Hyperlipidemia, has completed, sponsored by Temple University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to demonstrate that systematic self measurement of blood lipids reduces LDL cholesterol more effectively than standard care. The hypothesis is that cholesterol lowering medication adherence will be improved with self monitoring and reporting of frequent blood lipids and the percentage of patients achieving LDL goal will be greater than without home monitoring.
Primary Outcome
Comparison of serum LDL level between control and intervention subjects
Conditions Studied
Interventions
- DEVICE Self Monitoring Lipid Analyzer
Study Locations (1)
Pennsylvania
- Temple University Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2010-11 |
| Est. Completion | 2015-08 |
| Phase | Phase 4 |
What the finished NCT01212159 record still lists
NCT01212159 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 406-participant average among 35 other Hyperlipidemia trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Hyperlipidemia appearing as the primary indexed condition, and to 1 intervention - of which Self Monitoring Lipid Analyzer is the first listed.
NCT01212159 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01212159 about?
NCT01212159 is a clinical study titled "Telephone Based Management of Hyperlipidemia". The purpose of the study is to demonstrate that systematic self measurement of blood lipids reduces LDL cholesterol more effectively than standard care. The hypothesis is that cholesterol lowering medication adherence will be improved with self monitoring and reporting of frequent blood lipids and t...
What is the current status of trial NCT01212159?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2010-11. Estimated completion is 2015-08.
What conditions does trial NCT01212159 study?
This clinical trial studies the following conditions: Hyperlipidemia.
What interventions are being tested in trial NCT01212159?
The interventions under investigation include: Self Monitoring Lipid Analyzer (DEVICE).
Who is sponsoring clinical trial NCT01212159?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01212159 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hyperlipidemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01212159's enrollment target sits among peer trials
70 27th of 35 higher than 9 of 35 other Hyperlipidemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hyperlipidemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cholesterol and Pharmacogenetic Study
COMPLETED · Phase 4
-
Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy
COMPLETED · Phase 4
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Implementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of Patients With Atherosclerotic Cardiovascular Disease
RECRUITING · NA
-
Inspire HER: Inspiring the Heart and Emotions for Radical Health
RECRUITING · NA
-
A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia